CONFERENCE AGENDA

  • 09:00 - 09:30
    To be announced

    Roundtable Session

  • 09:30 - 10:00
    To be announced

    Opening Ceremony

  • 10:00 - 10:15

    Coffee Break & Networking

  • 10:15 - 11:00
    To be announced

    Keynote Session

  • 11:00 - 11:20
    Prof. David Marks

    CAR-T treatment updates

    Is Allogenic BMT Needed Post CAR-T Treatment in ALL?

  • 11:20 - 11:40
    Dr. Mohammed Hamieh

    CAR-T treatment updates

    CAR-T treatment Breaking New Frontiers

  • 11:40 - 12:00
    Dr. Daniel Couriel

    CAR-T treatment updates

    Access to Cellular Therapy

  • 12:00 - 12:10
    To be announced

    CAR-T treatment updates

    Panel Discussion

  • 12:10 - 13:15

    Lunch

  • 13:15 - 13:35
    Dr. Panagiotis Kottaridis, MD

    Challenges in Myeliod Malignancies

    Small Molecule Inhibitors in Acute Myeloid Leukemia

  • 13:35 - 13:55
    Dr. Leslie Lehmann

    Challenges in Myeliod Malignancies

    Role of Germline Mutation Profiling in the Selection of Donors for Allogenic BMT

  • 13:55 - 14:15
    To be announced

    Challenges in Myeliod Malignancies

    Update on MDS

  • 14:15 - 14:25
    To be announced

    Challenges in Myeliod Malignancies

    Panel Discussion

  • 14:55 - 15:15
    Prof. Koh Liang Piu

    Conditioning regimens in focus

    Graft Manipulation: Indications and Outcomes

  • 15:15 - 15:35
    Dr. Jaap Boelens

    Conditioning regimens in focus

    Conditioning Regimens in Metabolic Disorders

  • 15:35 - 15:55
    Dr. Josu De La Fuente

    Conditioning regimens in focus

    Haploidentical Transplantation in Hemoglobinopathies

  • 15:55 - 16:05
    To be announced

    Conditioning regimens in focus

    Panel Discussion

  • 16:05 - 16:20

    Coffee Break & Networking

  • 16:20 - 16:40

    What is New in GVHD Management

    Managing Chronic GVHD

  • 16:40 - 17:00
    Ben Carpenter

    What is New in GVHD Management

    Difficult Cases in GVHD

  • 17:00 - 17:20
    To be announced

    What is New in GVHD Management

    Update on Targeted Treatment in Lymphoma

  • 17:20 - 17:30
    To be announced

    What is New in GVHD Management

    Panel Discussion

  • 17:30 - 17:45
    To be announced

    Abstracts

  • 09:00 - 09:30
    To be announced

    Roundtable Session

  • 09:30 - 10:00
    To be announced

    Opening Ceremony

  • 10:00 - 10:15

    Coffee Break & Networking

  • 11:00 - 12:10
    To be announced

    New Perspectives in Cancer Immunotherapy

  • 12:10 - 13:15

    Lunch

  • 13:45 - 14:05
    To be announced

    Topic pending

  • 14:05 - 14:25
    Dr. Helen Sabzevari

    Ultra-CART: Transforming CAR-T Therapy

  • 14:25 - 14:45
    To be announced

    The Immunology of Longevity

  • 14:45 - 14:55
    To be announced

    Topic pending

    Panel Discussion

  • 14:55 - 15:15
    To be announced

    Neuro-regenerative Session

    ALS Related Neuroscience Talk

  • 15:15 - 15:35
    Dr. Angelo Vescovi

    Neuro-regenerative Session

    Phase 2 Trial in ALS – Results

  • 15:35 - 15:55
    To be announced

    Neuro-regenerative Session

    Trials on PD – Bluerock ltd Germany. University of Lunk - Parkinsons disease

  • 15:55 - 16:05
    To be announced

    Neuro-regenerative Session

    Panel Discussion

  • 16:05 - 16:20

    Coffee Break & Networking

  • 16:20 - 16:40
    To be announced

    Next Generation Therapies for the Future

    Allogenic UMSC Therapy in Type 1 Diabetes

  • 16:40 - 17:00
    To be announced

    Next Generation Therapies for the Future

    Chronic Lung Disease and Role of Cellular Therapy with a Focus on UAECell19

  • 17:00 - 17:20
    To be announced

    Next Generation Therapies for the Future

    Umbilical Cord Derived MSC and their Role in Fistula in Crohn's Disease

  • 17:20 - 17:30
    To be announced

    Next Generation Therapies for the Future

    Panel Discussion

  • 09:00 - 09:45
    To be announced

    Roundtable session

  • 09:45 - 10:05
    Dr. Jaap Boelens

    Immune Reconstitution post Allogenic BMT

  • 10:05 - 10:25
    Dr. Murtadha Al-Khabori

    Management of CMV Post Allogenic BMT

  • 10:25 - 10:45
    To be announced

    CMV Vaccine

  • 10:45 - 10:55
    To be announced

    Panel Discussion

  • 10:55 - 11:10

    Coffee Break & Networking

  • 11:10 - 11:30
    Dr. Rafat Abunour

    Managing Myeloma Complications of Treatment

  • 12:25 - 13:25

    Lunch

  • 13:25 - 13:50
    Dr. Franco Locatelli

    Gene Therapy in Haemoglobinopathies

    Gene Therapy Can Replace BMT - Yes

  • 13:50 - 14:15
    Ben Carpenter

    Gene Therapy in Haemoglobinopathies

    Gene Therapy Can Replace BMT - No

  • 14:15 - 14:25
    To be announced

    Gene Therapy in Haemoglobinopathies

    Discussion

  • 14:25 - 14:50
    Dr. Alfadel Alshaibani

    Update on Targeted Treatment in Lymphoma

  • 14:50 - 15:15
    Prof. Ashutosh Wechalekar

    Autologous BMT Lin Amyloid and Non-myeloma Plasma Cell Disorders

  • 15:15 - 15:20
    To be announced

    Panel Discussion

  • 15:20 - 15:35

    Coffee Break & Networking

  • 15:35 - 15:55
    Dr. Majid Kazmi

    Changing the paradigm in Multiple Sclerosis Treatment

    Multiple Sclerosis: Changing the Paradigm with Autologous Transplant

  • 15:55 - 16:15
    Dr. George Schett

    Changing the paradigm in Multiple Sclerosis Treatment

    CAR-T Treatment for Autoimmune Diseases: Where do we Stand?

  • 16:45 - 17:05
    Dr. Panagiotis Kottaridis, MD

    Focus on BMT Complications

    Pregnancy Post-transplant and Outcomes

  • 17:05 - 17:25
    Dr. Franzi

    Focus on BMT Complications

    Second Transplant in AML

  • 17:25 - 17:45
    Dr. Mohammed Abu Haleeqa

    Focus on BMT Complications

    Survivorship/Post CAR T – Setting up a Long-term Follow Up Clinic

  • 17:45 - 17:55

    Focus on BMT Complications

    Panel Discussion‎

  • 09:00 - 09:45
    To be announced

    Roundtable Session

  • 09:45 - 10:05
    To be announced

    iPS Related Talks

  • 10:05 - 10:25
    Prof. Kenji Osufoune

    iPS Related Talks

    iPS Cell Technology-based Regenerative Therapies for Kidney Diseases and Diabetes

  • 10:25 - 10:45
    Prof. Angelo

    iPS Related Talks

    Phase 1 Trial in Glioblastoma

  • 10:45 - 10:55
    To be announced

    iPS Related Talks

    Discussion

  • 10:55 - 11:10

    Coffee Break & Networking

  • 11:10 - 11:30
    Catherine Bollard

    Nutrition and Cancer

    Next Generation T Cell Therapy for Solid Tumors

  • 12:25 - 13:25

    Lunch

  • 13:25 - 13:45
    To be announced

    Setting Standards in Regnerative Medicine

  • 13:45 - 14:05
    To be announced

    Nutrigenomics

  • 15:20 - 15:35

    Coffee Break & Networking

  • 15:35 - 17:55
    To be announced

    Nursing

Download Program